PayZen
AI-powered patient financing platform for healthcare providers, offering interest-free payment plans.
Website: https://payzen.com/
Public sources
| Name | PayZen |
| Tagline | AI-powered patient financing platform for healthcare providers, offering interest-free payment plans. |
| Headquarters | San Francisco Bay Area, US |
| Founded | 2019 |
| Stage | Series B |
| Business Model | B2B |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | $100M+ (total disclosed ~$252,000,000) |
Links
Public sources
- Website: https://payzen.com/
- LinkedIn: https://www.linkedin.com/company/payzen
Executive Summary
Public sources
PayZen is a healthcare fintech startup that has raised over $250 million to deploy an AI-powered patient financing platform, positioning itself as a capital-intensive solution to the persistent problem of medical debt and provider collections. The company's core proposition is a "care now, pay later" model where it pays healthcare providers upfront while offering patients interest-free, fee-free payment plans, a wedge that differentiates it from traditional consumer credit and general-purpose buy-now-pay-later products [TechCrunch, Aug 2024]. Founded in 2019 by a team with deep fintech and consumer finance experience, PayZen is betting that its AI-driven underwriting can assess patient affordability more effectively than conventional credit scores, thereby expanding access to care and improving provider economics [Crunchbase News, Nov 2021].
CEO Itzik Cohen brings a relevant track record from his prior role as CEO and co-founder of consumer debt-resolution fintech Beyond Finance, and from earlier work at Prosper Marketplace, grounding the venture in consumer lending and credit risk fundamentals [Outcomes Rocket, Mar 2023]. The company's recent $32 million Series B and a $200 million debt facility, both closed in August 2024, signal investor confidence in its capital-intensive model, which requires significant balance sheet capacity to fund provider receivables [TechCrunch, Aug 2024]. Over the next 12-18 months, the key watchpoints will be the deployment velocity of the new debt capital, the demonstration of unit economics at scale, and the company's ability to convert its reported 35% average collections lift into durable, profitable provider contracts.
Lightly corroborated -- Core company description and funding details are confirmed by multiple independent sources; key operational claims (e.g., collections lift) remain company-reported.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Series B |
| Business Model | B2B |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | $100M+ (total disclosed ~$252,000,000) |
How the Company Got Here
Public sources
PayZen was founded in 2019 in the San Francisco Bay Area by Itzik Cohen, Tobias Mezger, and Ariel Rosenthal [Crunchbase]. The company’s initial public milestone was a $5 million seed round in early 2021, followed by a $15 million Series A in November of the same year [TechCrunch, Nov 2021]. This early capital supported the launch of its core product, an AI-powered patient financing platform for healthcare providers.
The company’s most significant funding event to date occurred in August 2024, when it announced a $32 million Series B led by NEA alongside a $200 million debt facility from Viola Credit [TechCrunch, Aug 2024]. This capital infusion, bringing total disclosed funding to approximately $252 million, marked a clear scaling milestone. Concurrently, the company reportedly expanded its C-suite, adding a CFO, COO, and CLO within six months of the Series B [Toarn].
Lightly corroborated -- Core founding and funding dates are corroborated by TechCrunch and Crunchbase; later-stage executive appointments are from a single source.
Product and Technology
Sources and analysis
The core product is an AI-powered patient financing platform that integrates into a healthcare provider’s existing digital billing flow. PayZen’s system assesses a patient’s ability to pay using proprietary machine learning models, then generates a personalized, interest-free, and fee-free payment plan [TechCrunch, Nov 2021]. The company positions this as a "care now, pay later" model, aiming to facilitate patient access to care by addressing affordability before or at the point of service, rather than solely as a collections tool [Crunchbase News, Nov 2021]. For providers, the platform’s primary value proposition is the guarantee of upfront payment; PayZen funds the provider immediately and assumes the credit risk of collecting from the patient over time [TechCrunch, Aug 2024].
Public claims about the technology’s speed and integration are ambitious but lack independent verification. The company states its underwriting, decisioning, and enrollment process takes less than a minute and that the platform can be implemented without IT costs, going live within four weeks [PayZen, blog]. It also claims a 78% enrollment success rate within a provider’s existing digital flow [Fintech of the Day, retrieved 2026]. The AI-driven underwriting is described as using thousands of data points to create personalized payment options, with one source specifying 30,000 data points to make an offer in minutes [PayZen, retrieved 2026] [Fintech of the Day, retrieved 2026]. An additional claimed capability is the ability to pre-screen patients for financial assistance eligibility, which could streamline charity care and discounting workflows [Finmed Partners, retrieved 2026].
- Tech stack (inferred from job postings). Open roles for senior machine learning engineers and data scientists list requirements for building and deploying models in production, experience with cloud platforms (AWS), and technologies like Python, PyTorch, and Kubernetes. This suggests a modern, cloud-native infrastructure for model training and serving.
- Implementation model. The platform is described as requiring no IT costs and a four-week launch timeline, indicating a SaaS model with API-based integration into provider systems like electronic health records (EHRs) and patient portals [PayZen, retrieved 2026]. The claim of "fully automated enrollment and servicing" points to a self-service model for patients after the initial underwriting offer [PayZen, retrieved 2026].
Lightly corroborated -- Core product mechanics are confirmed by multiple press reports. Detailed performance claims (enrollment rates, speed, implementation timeline) originate from company materials only.
Where the Demand Sits
Public sources The market for patient financing solutions is expanding as healthcare affordability becomes a structural pressure point for both consumers and providers, creating a clear wedge for technology that can underwrite medical bills outside traditional credit models.
Public sizing for the specific "care now, pay later" healthcare segment is not available from independent sources. However, the demand drivers are well-documented. The U.S. healthcare system is characterized by high out-of-pocket costs and rising patient financial responsibility, with an estimated $491 billion in patient out-of-pocket spending projected for 2024 [KFF, 2024]. This translates directly to provider collection challenges, as hospitals report that patient payments now constitute a significant portion of their revenue cycle, with bad debt and uncompensated care remaining persistent issues [Kaufman Hall, 2023]. These pressures create a clear tailwind for solutions that can convert patient balances into manageable payments, improving access to care and provider cash flow simultaneously.
Adjacent markets illustrate the scale of the underlying problem and potential solution space. The broader healthcare revenue cycle management market is valued at over $200 billion globally [Grand View Research, 2023], while the consumer-facing buy now, pay later (BNPL) market, which operates on a different credit model, reached $100 billion in transaction volume in the U.S. in 2023 [Worldpay, 2024]. PayZen's model sits at the intersection of these two large markets, applying a patient-centric, affordability-focused underwriting approach to a specific, high-stakes vertical.
Regulatory and macro forces are a mixed bag. On one hand, the No Surprises Act and heightened scrutiny of medical billing practices increase pressure on providers to offer transparent and affordable payment options. On the other, the regulatory environment for consumer lending and data privacy adds complexity. The company's model, which emphasizes zero interest and zero fees for patients, may help navigate some consumer-protection concerns, but the use of alternative data for underwriting remains an area of ongoing regulatory attention [CFPB, 2023].
| Metric | Value |
|---|---|
| U.S. Patient Out-of-Pocket Spend | 491 $B (2024 est.) |
| Healthcare RCM Market (Global) | 200 $B (2023) |
| U.S. BNPL Transaction Volume | 100 $B (2023) |
The available sizing analogs point to a large addressable problem, but the specific serviceable market for AI-driven, provider-embedded patient financing remains undefined by third-party research. The company's growth will be less about capturing a pre-defined market share and more about proving it can create a new category within the revenue cycle.
Lightly corroborated -- Market driver context is supported by independent healthcare economics reports; specific TAM for the company's niche is not publicly quantified.
Competitive Landscape
Sources and analysis
PayZen operates within a complex and fragmented competitive field, defined less by direct product clones and more by a spectrum of alternatives that healthcare providers use to manage patient financial responsibility. The company's primary competitive positioning is as a specialized, AI-driven financing layer embedded within provider workflows, distinct from both traditional consumer credit products and generic point-of-sale lending.
Given the absence of named competitors in the structured research, a direct comparison table cannot be constructed. The competitive analysis must therefore focus on mapping the broader ecosystem of alternatives.
From a segment perspective, competition occurs across three primary tiers. Incumbent financial institutions represent the first tier, including patient financing arms of major banks and specialized healthcare lenders like CareCredit (a Synchrony solution). These offer established, credit-score-based lending programs but are often criticized for high interest rates and complex enrollment processes that can occur post-care [Crunchbase News, November 2021]. Challenger fintechs form the second tier, encompassing both healthcare-specific 'buy now, pay later' (BNPL) providers and general-purpose BNPL platforms attempting to enter the healthcare vertical. These competitors often emphasize digital-first experiences but may lack PayZen's specific focus on pre-care affordability underwriting and deep integration with hospital revenue-cycle systems. Adjacent substitutes constitute the third and broadest tier, including provider self-pay programs, traditional collections agencies, and hospital charity-care/ financial assistance programs. These are not direct competitors for the financing transaction but compete for the same patient-dollar outcome, often with poorer patient satisfaction and lower collection rates for the provider.
PayZen's stated defensible edge rests on two interconnected pillars: its AI-driven underwriting model and its 'care now, pay later' wedge into provider workflows. The company claims its platform uses thousands of non-traditional data points to assess ability-to-pay, enabling it to offer interest-free plans to a broader patient population than credit-score-based models [TechCrunch, November 2021]. This data asset, if it generates consistently higher approval rates and lower default rates than alternatives, could become a durable advantage. The second edge is distribution; by integrating financing as a smooth part of the pre-care or point-of-care conversation, PayZen aims to become a utility within the provider's revenue cycle, potentially creating high switching costs. This edge is more perishable, as it depends on continued sales execution and product integration superiority over other digital challengers.
The company's most significant exposure likely lies in two areas. First, it faces channel competition from large, well-capitalized healthcare IT vendors (e.g., Epic, Cerner) or revenue-cycle management (RCM) giants that could decide to build or white-label a similar financing product, leveraging their existing, entrenched provider relationships. Second, it is exposed to competition from scaled fintech platforms with superior brand recognition among consumers. If a major player like Affirm or Klarna were to develop a dedicated, healthcare-optimized product with similar merchant-funded, zero-interest terms and achieve comparable provider integrations, they could use their consumer apps and trust to capture significant share.
A plausible 18-month competitive scenario hinges on the evolution of provider demand and capital market conditions. The 'winner' in this segment will be the company that demonstrably moves the needle on provider net collections while maintaining patient satisfaction, as measured by both quantitative metrics and qualitative case studies with named health systems. If providers prioritize deep, AI-native underwriting fully customized for medical affordability, PayZen's focused approach could allow it to out-execute more generalized fintechs. Conversely, the 'loser' would be any player that fails to prove superior unit economics or cannot secure the ongoing debt capital required to fund patient loans at scale, especially in a higher-interest-rate environment. PayZen's recent $200 million debt facility from Viola Credit [TechCrunch, August 2024] partially mitigates this risk for the near term, but the cost and scalability of that capital remain a long-term competitive variable.
Lightly corroborated -- Competitive mapping is inferred from the company's stated positioning versus described alternatives; no direct competitor names or funding details are publicly corroborated.
Opportunity
Public sources The prize for a successful execution of PayZen's model is a foundational role in the $4.5 trillion US healthcare economy, specifically by capturing a percentage of the estimated $500 billion in annual patient out-of-pocket medical expenses [KFF, 2023].
The headline opportunity is to become the default patient financing infrastructure for the US healthcare system. This outcome is reachable because the company's model directly addresses a structural pain point for providers: the shift of payment responsibility from insurers to patients has created a massive collections gap. PayZen's proposition,funding providers upfront while offering patients a no-interest alternative to traditional medical debt,aligns financial incentives across the care continuum. The evidence that makes this plausible is the company's ability to attract institutional capital for both equity and debt, including a $200 million warehouse facility from Viola Credit [TechCrunch, Aug 2024]. This scale of committed lending capital is a prerequisite for a platform that aims to finance patient payments at a systemic level, suggesting investors see a path to significant volume.
Growth could follow several concrete paths, each with identifiable catalysts.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Provider-Led Bundling | PayZen becomes the mandated or preferred financing option for large, multi-state health systems. | A major national health system signs an enterprise-wide contract, embedding PayZen into its standard patient financial communications. | The company's stated focus on hospitals, health systems, and large physician groups [Crunchbase News, Nov 2021] and its claim of increasing provider collection rates [TechCrunch, Aug 2024] are designed to appeal to this exact buyer. |
| Payor-Provider Partnership | Health insurers or employer health plans white-label PayZen's platform as a member benefit to reduce claim denials and improve patient satisfaction. | A strategic investment or partnership with a top-10 national health insurer is announced. | The involvement of a syndicate of insurance companies in the 2024 debt facility [TechCrunch, Aug 2024] indicates a foundational relationship with capital providers in the insurance sector, which could evolve into a commercial distribution channel. |
Compounding success would likely manifest as a data and underwriting flywheel. Each patient financing transaction generates proprietary repayment data on medical affordability, a dataset distinct from traditional credit bureaus. As this dataset grows, the AI models for assessing ability-to-pay become more accurate, potentially lowering loss rates and allowing the company to approve a wider patient population. This improved unit economics could, in turn, fund more aggressive customer acquisition or enable the company to share savings with providers, creating a classic data network effect. While direct evidence of this flywheel in motion is not publicly available, the company's core product claim is built on AI-driven underwriting using thousands of data points [PayZen, blog], establishing the foundational intent.
The size of the win can be framed by looking at a comparable: public fintech Affirm, which operates a general-purpose buy-now-pay-later platform, reached a market capitalization of approximately $10 billion in early 2025. A healthcare-specific financing platform that achieves default infrastructure status in a market of comparable transaction volume but with potentially better unit economics (due to provider-side payments and integrated workflows) could command a similar or greater valuation multiple. If the Provider-Led Bundling scenario plays out, capturing even a single-digit percentage of the patient out-of-pocket expense market would represent a multi-billion dollar annual financing volume business. This is a scenario-based outcome, not a forecast.
Lightly corroborated -- The core opportunity thesis is supported by public reports on healthcare spending and the company's funding structure. Specific growth scenarios are extrapolated from stated customer targets and investor composition, but named customer or partnership catalysts are not yet public.
Sources
Public sources
[TechCrunch, August 2024] PayZen secures $32M Series B, $200M debt facility to expand ‘care now, pay later’ offering | https://techcrunch.com/2024/08/13/payzen-secures-23m-series-b-led-by-nea-and-200m-in-debt-to-expand-care-now-pay-later-offering/
[TechCrunch, November 2021] PayZen secures $15M Series A for ‘care now, pay later’ healthcare platform | https://techcrunch.com/2021/11/17/payzen-secures-15m-series-a-for-care-now-pay-later-healthcare-platform/
[Crunchbase News, November 2021] Medical Fintech Startup PayZen Raises $15M To Grow Its ‘Care Now, Pay Later’ Model | https://news.crunchbase.com/startups/medical-fintech-startup-payzen-ai-pay-later/
[Outcomes Rocket, March 2023] Making Healthcare Affordable with Itzik Cohen | https://outcomesrocket.health/payzen/2022/03/
[Fintech One-on-One / Future Nexus, October 2023] Itzik Cohen, Founder & CEO of PayZen, on bringing financial health to healthcare | https://www.heyfuturenexus.com/itzik-cohen-founder-ceo-of-payzen-on-bringing-financial-health-to-healthcare/
[The Real Maxime Podcast, November 2023] Itzik Cohen, PayZen | https://podcasts.apple.com/us/podcast/itzik-cohen-payzen-the-fintech-series/id1655922798?i=1000636288292
[PayZen, blog] PayZen’s “Care Now, Pay Later” Mission | https://blog.payzen.com/payzens-care-now-pay-later-mission-9a74db90db18?gi=60e6759686c6
[Crunchbase] PayZen - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/payzen-6da3
[Toarn] Article retrieved 2026 | https://toarn.com/
[Fintech of the Day, retrieved 2026] Article retrieved 2026 | https://fintechoftheday.com/
[Finmed Partners, retrieved 2026] Article retrieved 2026 | https://finmedpartners.com/
[KFF, 2024] Health Spending Explorer | https://www.healthsystemtracker.org/health-spending-explorer/
[Kaufman Hall, 2023] National Hospital Flash Report | https://www.kaufmanhall.com/insights/research-report/national-hospital-flash-report
[Grand View Research, 2023] Healthcare Revenue Cycle Management Market Size Report | https://www.grandviewresearch.com/industry-analysis/healthcare-revenue-cycle-management-market
[Worldpay, 2024] Global Payments Report | https://worldpay.globalpaymentsreport.com/
[CFPB, 2023] Consumer Financial Protection Bureau Report | https://www.consumerfinance.gov/about-us/newsroom/
[KFF, 2023] Health Costs and Budgets | https://www.kff.org/health-costs/
Articles about PayZen
- PayZen's $200 Million Debt Facility Funds a Bet on Medical Bills Without Interest — The five-year-old fintech uses AI to underwrite patient affordability, promising hospitals upfront payment while offering zero-interest plans.